KRAS degradation induces rapid lung cancer regression in preclinical mouse models
KRAS is one of the oncogenes most frequently altered in cancer, mutating in approximately one-third of lung adenocarcinomas. For decades, it was considered undruggable, until the recent approval of the first inhibitors against ...
May 27, 2026
0
4









